Relmada Therapeutics, Inc. · NASDAQ:RLMD
Adage Capital Management, L.P.'s stake in Relmada Therapeutics, Inc. fell to 4.54% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 13, 2026
Adage Capital Management, L.P.'s stake in Relmada Therapeutics, Inc. fell to 4.54%, 4,763,158 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G/A).
- Stake
- 4.54%
- Shares
- 4,763,158
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 4.54% | 4,763,158 |
| Robert Atchinson | 4.54% | 4,763,158 |
| Phillip Gross | 4.54% | 4,763,158 |
Source
Related
- Relmada Therapeutics, Inc.
- Adage Capital Management, L.P.
- Relmada Therapeutics, Inc. shareholders
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2026
- Form 4 · Shenouda Maged · Sep 11, 2026
- Form 4 · Traversa Sergio · Sep 11, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · Millennium Management LLC · Jun 22, 2026